Tag: UnitedHealth Group

EDEN PRAIRIE, Minn., and LAFAYETTE, La. – Optum, part of UnitedHealth Group, has agreed to buy LHC Group, a home health provider, for $170 per share of common stock in a play to extend value-based care into the homes of patients.  LHC Group’s history of quality home and community-based care matched with Optum’s extensive value-based care experiences and resources will accelerate the combined company’s ability to deliver integrated care, improving outcomes and patient...

WASHINGTON – The Department of Justice, along with attorneys general in Minnesota and New York, have filed a lawsuit to stop UnitedHealth Group’s proposed $13 billion acquisition of Change Healthcare.  The civil complaint, filed in the U.S. District Court for the District of Columbia, alleges the deal would harm competition in commercial health insurance markets, as well as in the market for a technology used by health insurers to process health insurance claims and reduce health...

ALEXANDRIA, Va. – The National Community Pharmacists Association reiterated its call to the Federal Trade Commission to block UnitedHealth Group’s acquisition of Change Healthcare in a recent letter. UHG owns United Healthcare, a major health insurer, and Optum, a pharmacy benefit manager and mail order pharmacy. NCPA CEO B. Douglas Hoey has warned the merger would create a massively unfair advantage in the marketplace for a company that is already dominant and would threaten fair competition,...

HARTFORD, Conn. - CareCentrix has added Charles Berg, a former senior executive at UnitedHealth Group, WellCare and Oxford Health, to its board of directors. He previously served on the board of Turn-Key Health, a palliative care company that was acquired by CareCentrix in May. The acquisition of Turn-Key Health and Berg's position on the board represent the next stage in CareCentrix's plan to provide more access to home-based services for all patients, including those with advanced illnesses....

EDEN PRAIRIE, Minn., and FLINT, Mich. - UnitedHealth Group's Optum division will pay about $300 million to buy Diplomat, a provider of specialty pharmacy and infusion services, according to news reports. Diplomat focuses on managing specialty medications, including oncology and immunology, and provides specialized infusion therapies in all 50 states and Washington, D.C. “With its focus in specialty and infusion services, Diplomat has a proven track record of solving the unique challenges...